Sonoma Pharmaceuticals, Inc. Warrants
SNOAW
SNOAW was delisted on the 22nd of January, 2020.
6 hedge funds and large institutions have $1.27M invested in Sonoma Pharmaceuticals, Inc. Warrants in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
20% more funds holding
Funds holding: 5 → 6 (+1)
14% more capital invested
Capital invested by funds: $1.12M → $1.27M (+$152K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$21.5K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$1.14K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$927 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$76K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$15.2K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10.9K |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$505 |
SNOAW Hedge Fund Activity: Q1 2017 in Review
6 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) for Q1 2017, worth a combined $1.27M — up 14% from $1.12M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new SNOAW positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $21.5K. The largest seller was Ionic Capital Management, exiting entirely with an estimated $76K sold.
- 6 institutional investors held Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) as of Q1 2017, up from 5 in Q4 2016.
- Funds reported $1.27M of Sonoma Pharmaceuticals, Inc. Warrants stock for Q1 2017, up 14% quarter-over-quarter.
- 3 funds opened new Sonoma Pharmaceuticals, Inc. Warrants positions in Q1 2017 and 1 closed out, a net change of +2 holders.
- The largest Sonoma Pharmaceuticals, Inc. Warrants buyer in Q1 2017 was Virtu KCG Holdings, an estimated $21.5K added.
- The largest Sonoma Pharmaceuticals, Inc. Warrants seller in Q1 2017 was Ionic Capital Management, an estimated $76K sold.
Based on aggregated 13F filings for Q1 2017.